Blog
Stock Market News: HP Stays Strong; Boeing Waits for the FAA
The stock market was open for business on Wednesday morning, but many investors got an early start to the Thanksgiving holiday. As of 11 a.m. EST, the Dow Jones Industrial Average (DJINDICES: ^DJI)
Valve's "Half-Life: Alyx" Will Be Virtual Reality's First Killer App
Steep hardware prices and a lack of big-budget, must-have content have been key limiting factors in the growth of virtual reality (VR). However, headset prices are starting to come down, and VR's
What to Expect When Dollar General Reports Earnings
Dollar store titan Dollar General (NYSE: DG) is set to release its fiscal third-quarter earnings scorecard next week on Dec. 5 before the markets open for trading. The consumer staples merchant has
This 13.7%-Yielding Stock Plans to Keep Increasing Its Dividend in 2020
Western Midstream (NYSE: WES) has quietly put together an excellent dividend track record. The master limited partnership (MLP) has increased its payout in each of the past 27 consecutive quarters
Is Lexicon Pharmaceuticals a Buy?
It's been a rough year for Lexicon Pharmaceuticals (NASDAQ: LXRX). In fact, it's been a rough five years for the pharmaceutical stock, which has lost 49% in that span.
The business has struggled to
Where Will Procter & Gamble Be in 1 Year?
Over the past two years, Procter & Gamble (NYSE: PG) stock has nearly doubled as the company has made some major changes. It shed businesses it didn't feel were core to operations, and consolidated
If You Invested $1,000 in AMD's IPO, This Is How Much Money You'd Have Now
Advanced Micro Devices (NASDAQ: AMD), the second-largest maker of x86 CPUs and GPUs in the world, was once just a scrappy start-up based in a living room. It was founded in 1969, just one year after
How Much Does Netflix Need Stranger Things?
Netflix's (NASDAQ: NFLX) Stranger Things is perhaps the most bankable franchise in streaming television right now.
The series has earned over 30 Emmy nominations and its season three debut has been
Agios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare Genetic Diseases: What It Means for Investors
There's an old adage in biotech -- raise capital when you can, not when you have to -- that Agios Pharmaceuticals (NASDAQ: AGIO) seems to have taken to heart. The biotech ended the third quarter
3 Great Reasons to Buy Guardant Health
Chances are, you know someone whose life has been affected by cancer, a disease that will kill more than 600,000 people in the United States this year. Guardant Health (NASDAQ: GH) is fighting back.
Which Retailers Have Free Holiday Shipping?
Amazon (NASDAQ: AMZN) has changed consumer expectations around product shipping. The online retailer has made its paid Prime membership, which includes free two-day (and sometimes one-day) shipping
2020 Could be Another Big Year for Energy Transfer
This year has been another record one on the financial side for Energy Transfer (NYSE: ET). The pipeline giant is on track to generate between $11 billion and $11.1 billion in adjusted EBITDA this
Disney's Video Bundle Is Helping Grab a Million Subscribers Every Day
It's been a little over two weeks since Disney (NYSE: DIS) launched Disney+, its highly anticipated video-streaming service. Despite some initial technical hiccups, Disney grabbed 10 million
Will Aurora Run Out of Money?
Aurora Cannabis (NYSE: ACB) saw sales rise by 154% last quarter and even recorded a profit. However, with Aurora's bottom line benefiting from a large unrealized gain on its derivative liability and
Is Inovio Pharmaceuticals a Buy?
Poring through the many small-cap biotechs out there, investors might have picked up on a company called Inovio Pharmaceuticals (NASDAQ: INO). With a market cap of just $260.5 million, this little
Macy's Offers More Excuses as Its Growth Withers
Macy's (NYSE: M) stock has lost half its market value so far this year as its comparable-store sales declined, its margins contracted, and its turnaround efforts fizzled out. Its stores have
Here's What Consumers Anticipate Spending Between Thanksgiving and Cyber Monday
Though the holiday season spans many weeks, it's often the case that consumers do the bulk of their shopping from Thanksgiving through Cyber Monday. And Deloitte's 2019 pre-Thanksgiving pulse survey
1 Overlooked Place Where Dividend Investors Can Score a 4%+ Yield
Because America is currently the largest oil-producing country in the world, many investors tend to overlook our neighbor to the north, Canada, which itself is a top-five oil producer. That's
Better Buy: iQiyi vs. Huya
iQiyi (NASDAQ: IQ) and Huya (NYSE: HUYA), two major players in China's streaming video market, went public last year. iQiyi went public last March at $18. Its stock surged to nearly $30 earlier this
3 Stocks I'm Grateful For
Thanksgiving is a time to gather with friends and family -- and be grateful. But there's no reason we can't also take the time over the holidays to be grateful about the members of our portfolio
Mergerpalooza and Its Ramifications
In this episode of MarketFoolery, host Chris Hill chats with analyst Jason Moser about three big mergers. Tiffany (NYSE: TIF) is being tucked into Louis Vuitton, which looks like a great move for
3 Reasons This Top Renewable-Energy Stock Is Set Up for More Success in 2020
Brookfield Renewable Partners (NYSE: BEP) has been having an amazing year. The renewable-energy company's stock has already skyrocketed a market-pulverizing 78% on the year. Add in its high-yielding
3 Reasons Papa John’s Pizza Stock Is a Buy
It's time for hungry restaurant investors to grab a slice of Papa John's (NASDAQ: PZZA) proverbial financial pie. What's so exciting about this U.S.-based pizza chain at the moment? It's a
Is Adobe Stock a Buy?
It's been a great five-year run for creative software specialist Adobe Systems (NASDAQ: ADBE), with shares sporting a 324% gain in that span. With 2019 coming to a close, the company issued an
Ambarella Powers Forward Despite Continued Macroeconomic Strife
Ambarella (NASDAQ: AMBA) released better-than-expected fiscal third-quarter 2020 results after the market closed on Monday, notably including a return to top-line growth with the help of an early


